Warren James Huff Net Worth & Insider Trades
Warren James Huff - Chief Executive Officer, Reata Pharmaceuticals Inc
What is Warren James Huff's Net Worth?
The current estimated net worth of Reata Pharmaceuticals Inc's Chief Executive Officer, Warren James Huff, is estimated to be about $39.29M . Warren James Huff owns about 37,741 units of Reata Pharmaceuticals Inc common stock. In the last 7 years at Reata Pharmaceuticals Inc, Warren James Huff has sold an estimated value of $26.16M worth.
What is Warren James Huff's Past Insider Trading?
Warren James Huff's largest purchase order was 179,823 units , worth over $1.25M on June 2, 2016. Warren James Huff's largest sale order was 81,657 units , worth over $14.29M on November 10, 2020. In total, Warren James Huff has made about 15 transactions over 7 years of their time at Reata Pharmaceuticals Inc. Warren James Huff usually trades in January, with the busiest year in 2023. The most recent transaction was a sale order of 75,000 units , worth over $6.41M on March 3, 2023.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Warren James Huff
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What was Warren James Huff's Salary in 2020?
As Chief Executive Officer of Reata Pharmaceuticals Inc, Warren James Huff has a total base salary of $636,400 . Warren James Huff received compensation valued at about $6,396,130 in 2020 after becoming Chief Executive Officer. The vast majority of their compensation came in the form of a bonus of $413,660 , other earnings, plans or compensations of $5,000 , and other earnings, plans or compensations of $5,000 .
What is Warren James Huff's' Mailing Address?
- Mailing address is C/o Reata Pharmaceuticals, Inc. 2801 Gateway Dr. Suite 150 Irving TX 75063 TX
Reata Pharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Total
|
---|---|---|---|---|---|---|---|
J. Warren Huff | 2020 | $636,400 | $413,660 | - | $5,000 | $5,000 | $6,396,130 |
J. Warren Huff | 2019 | $578,500 | $600,540 | - | $16,715 | $16,715 | $5,542,605 |
J. Warren Huff | 2018 | $534,000 | $400,500 | - | - | - | $934,500 |
Manmeet S. Soni | 2020 | $545,900 | $445,700 | - | $136,125 | $136,125 | $4,465,894 |
Manmeet S. Soni | 2019 | $179,385 | $408,873 | - | $70,243 | $70,243 | $12,261,587 |
Dawn C. Bir | 2020 | $422,000 | $239,900 | - | $5,000 | $5,000 | $3,871,542 |
Dawn C. Bir | 2019 | $375,100 | $287,550 | - | $3,500 | $3,500 | $1,975,899 |
Colin J. Meyer, M.D. | 2020 | $513,951 | $381,400 | - | - | - | $4,233,520 |
Colin J. Meyer, M.D. | 2019 | $445,600 | $389,467 | - | - | - | $2,182,780 |
Colin J. Meyer, M.D. | 2018 | $417,000 | $208,500 | - | - | - | $625,500 |
Michael D. Wortley | 2020 | $421,100 | $339,500 | - | - | - | $3,965,242 |
Michael D. Wortley | 2019 | $382,800 | $341,400 | - | - | - | $2,033,949 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/1358762/000156459021022192/reta-def14a_20210610.htm
What are Reata Pharmaceuticals Inc's Past Insider Trades?
Reata Pharmaceuticals Inc's most recent insider trade came on September 18, 2023 by Andrea Loewen who sold 3,175 units worth $546.18K . In the last 7 years, insiders at Reata Pharmaceuticals Inc have sold an estimated value of $178.68M and bought an estimated value of $141.88M worth of shares. Insider trading is most common in June, with the busiest year in 2023. The most active traders at the company are R. Kent McGaughy Jr., Douglas Jason Wilson, Executive VP Operations, and Elaine Castellanos, VP .
REATA PHARMACEUTICALS INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |